RECRUITING

Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)

Official Title

Prospective Randomized Controlled Trial Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Quick Facts

Study Start:2023-12-08
Study Completion:2026-03-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06476145

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 18 years or older
  2. 2. Ability to provide informed consent
  3. 3. Patient scheduled to undergo colonoscopy for the evaluation and removal of colon polyps
  4. 4. Non-pedunculated polyps ≥ 20 mm size
  1. 1. Pedunculated polyps
  2. 2. Inflammatory bowel disease
  3. 3. Inability to provide informed consent
  4. 4. Lesions \< 20 mm in size (largest dimension)
  5. 5. Lesion involves the lips of the ileocecal valve, is located at the appendiceal orifice and/or is fully circumferential.
  6. 6. Any standard contraindication, including pregnancy, to anesthesia and/or colonoscopy

Contacts and Locations

Study Contact

Diana Paredes, RN
CONTACT
407-303-5503
Diana.Paredes@adventhealth.com
Petronio Martins, MHA
CONTACT
407-303-5503
Petronio.martins@adventhealth.com

Principal Investigator

Dennis Yang, MD
PRINCIPAL_INVESTIGATOR
AdventHealth

Study Locations (Sites)

AdventHealth
Orlando, Florida, 32804
United States

Collaborators and Investigators

Sponsor: AdventHealth

  • Dennis Yang, MD, PRINCIPAL_INVESTIGATOR, AdventHealth

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-08
Study Completion Date2026-03-08

Study Record Updates

Study Start Date2023-12-08
Study Completion Date2026-03-08

Terms related to this study

Additional Relevant MeSH Terms

  • Adenoma Colon Polyp